Loading data
MDXGNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 418.63 m USD | 348.88 m USD | 321.48 m USD | 267.84 m USD | 242.02 m USD |
| Cost of revenue | 73.01 m USD | 60.07 m USD | 54.63 m USD | 48.32 m USD | 39.63 m USD |
| Gross profit | 345.62 m USD | 288.81 m USD | 266.84 m USD | 219.53 m USD | 202.39 m USD |
| Research and development expense | 15.1 m USD | 12.34 m USD | 12.67 m USD | 12.7 m USD | 9.93 m USD |
| Selling, general and administrative expense | 266.19 m USD | 225.09 m USD | 211.12 m USD | 208.67 m USD | 194.85 m USD |
| Operating profit | 63.89 m USD | 58.87 m USD | 37.12 m USD | -14.73 m USD | -7.05 m USD |
| Profit before tax | 66.26 m USD | 57.29 m USD | 30.63 m USD | -19.75 m USD | -12.05 m USD |
| Income tax expense | 17.68 m USD | 15.3 m USD | -36.81 m USD | 206 k USD | 247 k USD |
| Net income (reported basis) | 48.58 m USD | 42.42 m USD | 58.23 m USD | -30.2 m USD | -10.29 m USD |
| Net income attributable to common shareholders | — | — | — | -36.78 m USD | -16.42 m USD |
| Basic earnings per share | 0.33 USD/share | 0.29 USD/share | 0.4 USD/share | -0.33 USD/share | -0.15 USD/share |
| Diluted earnings per share | 0.32 USD/share | 0.28 USD/share | 0.37 USD/share | -0.33 USD/share | -0.15 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.